Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A malignant glioma that involves the brain.
Biomarker and diagnostic research for brain glioma has been reported in the published literature.
9 clinical trials registered, 4 recruiting. Interventions under study include drug therapy, medical devices, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE2, 1 PHASE1, 3 EARLY_PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT04908709](https://clinicaltrials.gov/study/NCT04908709) |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 6:36 PM UTC
Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors |
NA |
Emory University |
RECRUITING |
[NCT06747728](https://clinicaltrials.gov/study/NCT06747728) | Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain | NA | The First Affiliated Hospital of Zhengzhou University | RECRUITING |
[NCT06132685](https://clinicaltrials.gov/study/NCT06132685) | Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial | PHASE2 | Emory University | RECRUITING |
[NCT04943913](https://clinicaltrials.gov/study/NCT04943913) | Study of GC101 TIL in Brain Glioma (Soochow2) | EARLY_PHASE1 | Shanghai Juncell Therapeutics | UNKNOWN |
[NCT06018363](https://clinicaltrials.gov/study/NCT06018363) | Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection | PHASE1 | Dushu Lake Hospital Affiliated to Soochow University | UNKNOWN |
259 publications have been identified in PubMed for brain glioma. Research spans Basic Science / Preclinical (27%), Review / Meta-Analysis (25%), and Gene Therapy / Novel Therapeutics (17%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 70 | 27% |
Research summaries | 66 | 25% |
New treatment approaches | 45 | 17% |
Testing and diagnosis research | 42 | 16% |
Clinical study results | 14 | 5% |
Disease patterns and progression | 13 | 5% |
Patient case studies | 6 | 2% |
Other research | 3 | 1% |
Bessler N (2026). [PMID: 41492091](https://pubmed.ncbi.nlm.nih.gov/41492091/). *Nat Cancer*. [Basic Science / Preclinical]
Mignone C (2026). [PMID: 41274769](https://pubmed.ncbi.nlm.nih.gov/41274769/). *Neuroimaging Clin N Am*. [Review / Meta-Analysis]
Sussman JH (2026). [PMID: 40974256](https://pubmed.ncbi.nlm.nih.gov/40974256/). *Neuro Oncol*. [Diagnostic / Biomarker]
Tang F (2026). [PMID: 41689740](https://pubmed.ncbi.nlm.nih.gov/41689740/). *Molecular biology reports*. [Clinical Trial Publication]
Romanowicz A (2026). [PMID: 41399659](https://pubmed.ncbi.nlm.nih.gov/41399659/). *Biochem Med (Zagreb)*. [Review / Meta-Analysis]
Hasani F (2026). [PMID: 41503680](https://pubmed.ncbi.nlm.nih.gov/41503680/). *Journal of cellular and molecular medicine*. [Clinical Trial Publication]
Ding S (2026). [PMID: 42037585](https://pubmed.ncbi.nlm.nih.gov/42037585/). *CNS Neurosci Ther*. [Epidemiology / Natural History]
Juncà A (2026). [PMID: 41521239](https://pubmed.ncbi.nlm.nih.gov/41521239/). *Sci Rep*. [Basic Science / Preclinical]
Xu X (2026). [PMID: 42016766](https://pubmed.ncbi.nlm.nih.gov/42016766/). *Exploration (Beijing)*. [Basic Science / Preclinical]
Yan J (2026). [PMID: 42145684](https://pubmed.ncbi.nlm.nih.gov/42145684/). *Biomed Opt Express*. [Diagnostic / Biomarker]